1. Home
  2. BYFC vs PYPD Comparison

BYFC vs PYPD Comparison

Compare BYFC & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Broadway Financial Corporation

BYFC

Broadway Financial Corporation

HOLD

Current Price

$7.48

Market Cap

71.7M

Sector

Finance

ML Signal

HOLD

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

HOLD

Current Price

$4.25

Market Cap

81.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BYFC
PYPD
Founded
1946
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Savings Institutions
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.7M
81.7M
IPO Year
2013
2014

Fundamental Metrics

Financial Performance
Metric
BYFC
PYPD
Price
$7.48
$4.25
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$12.00
AVG Volume (30 Days)
2.5K
55.5K
Earning Date
04-27-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$184,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.71
N/A
52 Week Low
$5.51
$2.38
52 Week High
$8.85
$5.12

Technical Indicators

Market Signals
Indicator
BYFC
PYPD
Relative Strength Index (RSI) 38.21 48.73
Support Level $7.19 $4.14
Resistance Level $7.54 $4.38
Average True Range (ATR) 0.10 0.21
MACD -0.05 -0.00
Stochastic Oscillator 26.46 52.27

Price Performance

Historical Comparison
BYFC
PYPD

About BYFC Broadway Financial Corporation

Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States. The Bank's business consists of deposits from the general public and using such deposits, together with borrowings and other funds, to make mortgage loans secured by residential properties and commercial real estate. Its deposits consist of passbook savings accounts, checking accounts, and negotiable order of withdrawal accounts, money market accounts and fixed-term certificates of deposit. The revenue is derived from interest income on loans and investments.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: